Mpex Pharma Raising $40 Million
Mpex Pharmaceuticals Inc., a San Diego-based drug developer focused on antibiotic resistance, has held a $27.5 million first close on its Series D round that is targeting a total of $40 million. Investor Growth Capital led the tranche, and was joined by return backers investors SV Life Sciences, HBM BioVentures, Aberdare Ventures and Adams Street Partners.
10 February 2009•4 mins read
